REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, the Licensee has provided the IC with the Commercial Development Plan in Appendix E, under which the Licensee intends to bring the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D.
Appears in 28 contracts
Samples: Agreement (Cartesian Therapeutics, Inc.), Patent License Agreement – Exclusive (Kyverna Therapeutics, Inc.), Patent License Agreement – Exclusive (Kyverna Therapeutics, Inc.)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, the Licensee has provided the IC PHS with the Commercial Development Plan in Appendix E, under which the Licensee intends to bring the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D.
Appears in 27 contracts
Samples: Health Service Patent License Agreement, Patent License Agreement (Kinemed Inc), Patent License Agreement (Kinemed Inc)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 9.01 Prior to signing this Agreement, the Licensee has provided the IC with to PHS the Commercial Development Plan in at Appendix EF, under which the Licensee intends to bring the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D.E.
Appears in 14 contracts
Samples: Patent License Agreement (20/20 GeneSystems, Inc.), Patent License Agreement (Trinity Biotech PLC), Patent License Agreement (Trinity Biotech PLC)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, the Licensee has provided the IC with the Commercial Development Plan in Appendix E, under which the Licensee intends to bring the subject matter of develop the Licensed Patent Rights to Products or Licensed Processes with the point intent of achieving the Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D.
Appears in 2 contracts
Samples: Patent License Agreement (Dynamics Special Purpose Corp.), Patent License Agreement (Dynamics Special Purpose Corp.)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, the Licensee has provided the IC with the Commercial Development Plan in Appendix E, under which the Licensee (or its Affiliate or Sublicensee) intends to bring develop the subject matter of the Licensed Jointly Owned Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D.
Appears in 1 contract
Samples: Public Health Service (Lixte Biotechnology Holdings, Inc.)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, the Licensee has provided the IC with the Commercial Development Plan in Appendix E, under which the Licensee intends to bring the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D..
Appears in 1 contract
Samples: Public Health Service (LogicBio Therapeutics, Inc.)
REPORTS ON PROGRESS, BENCHMARKS, SALES, AND PAYMENTS. 9.1 Prior to signing this Agreement, the Licensee has provided the IC with the Commercial Development Plan in Appendix E, under which the Licensee intends to use Commercially Reasonable Efforts to bring Licensed Product(s) or Licensed Process(es) within the subject matter of the Licensed Patent Rights to the point of Practical Application. This Commercial Development Plan is hereby incorporated by reference into this Agreement. Based on this plan, performance Benchmarks are determined as specified in Appendix D.
Appears in 1 contract
Samples: Patent License Agreement ‒ Exclusive (Iovance Biotherapeutics, Inc.)